Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Healthcare Contract Development And Manufacturing Organization Market Growth & Trends
The global healthcare contract development and manufacturing organization market size is expected to reach USD 471.0 billion by 2030 at a CAGR of 9.2% according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends.
Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on a contract basis. An increase in the outsourcing by pharmaceutical companies, expansions in the pharmaceutical industry, and the support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth in the forecast period.
In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to the increasing demand for medical devices in emerging countries, various companies are shifting their focus on research and development and outsourcing medical devices. Also, the rise in outsourcing of R&D and the growing competency of CDMOs are expected to further contribute to the growing demand for early-stage development CDMOs by life science companies.
However, increasing logistic costs, serialization issues faced by healthcare organizations, and the threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.
Healthcare Contract Development and Manufacturing Organization Market Report Highlights
Healthcare Contract Development And Manufacturing Organization Market Growth & Trends
The global healthcare contract development and manufacturing organization market size is expected to reach USD 471.0 billion by 2030 at a CAGR of 9.2% according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends.
Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on a contract basis. An increase in the outsourcing by pharmaceutical companies, expansions in the pharmaceutical industry, and the support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth in the forecast period.
In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to the increasing demand for medical devices in emerging countries, various companies are shifting their focus on research and development and outsourcing medical devices. Also, the rise in outsourcing of R&D and the growing competency of CDMOs are expected to further contribute to the growing demand for early-stage development CDMOs by life science companies.
However, increasing logistic costs, serialization issues faced by healthcare organizations, and the threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.
Healthcare Contract Development and Manufacturing Organization Market Report Highlights
- The contract manufacturing segment dominated the market with a revenue share of 73.4% in 2021 due to increasing in the outsourcing of manufacturing services by pharmaceutical and medical device companies
- The preclinical /segment is expected to register the highest CAGR of 10.1% in the forecast period due to the rising prevalence of many lifestyle-influenced diseases
- North America dominated the healthcare contract development and manufacturing organization market with the largest revenue share of 41.0% in 2021 owing to the presence of a large number of CROs and CMOs in the region
- The Asia Pacific is projected to witness the fastest growth during the forecast period owing to low-cost service offered by Asian CROs and CMOs
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding strategy framework, competitor categorization
1.9.4. Objective 4: Understanding key service scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing outsourcing services by pharmaceutical companies
3.4.1.2. Rising investment in R&D
3.4.1.3. Growing pharmaceutical industry
3.4.1.4. Increasing demand for one-stop-shop CDMOs
3.4.2. Market Restraint Analysis
3.4.2.1. Compliance issues while outsourcing
3.4.2.2. Changing scenarios in developing countries
3.4.2.3. Regulatory and legal compliance
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Healthcare CDMO: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.3.1. Mergers & Acquisitions
3.5.3.2. Geographic Expansions
3.5.3.3. Partnerships
3.5.3.4. Launch
3.5.3.5. Collaborations
CHAPTER 4. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: SEGMENT ANALYSIS, BY SERVICES, 2018 - 2030 (USD BILLION)
4.1. Definitions & Scope
4.2. Service market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Healthcare Contract Development & Manufacturing Organization Market, by services, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Contract Development
4.5.2. Small Molecule
4.5.2.1 Preclinical
4.5.2.1.1 Bioanalysis and DMPK studies
4.5.2.1.2 Toxicology Testing
4.5.2.1.3 Other Preclinical Services
4.5.2.2 Clinical
4.5.2.2.1 Phase I
4.5.2.2.2 Phase II
4.5.2.2.3 Phase III
4.5.2.2.4 Phase IV
4.5.2.3 Laboratory Services
4.5.2.3.1 Bioanalytical Services
4.5.2.3.2 Analytical Services
4.5.3. Large Molecule
4.5.3.1 Cell line development
4.5.3.2 Process development
4.5.3.2.1 Upstream
4.5.3.2.1.1 Microbial
4.5.3.2.1.2 Mammalian
4.5.3.2.1.3 Others
4.5.3.2.2 Downstream
4.5.3.2.2.1 MABs
4.5.3.2.2.2 Recombinant Proteins
4.5.3.2.2.3 Others
4.5.4. Contract Manufacturing
4.5.4.1 Small Molecule
4.5.4.2 Large Molecule
4.5.4.2.1 MABs
4.5.4.2.2 Recombinant Proteins
4.5.4.2.3 Others
4.5.4.3 High Potency API
4.5.4.4 Finished Dose Formulations
4.5.4.4.1 Solid Dose Formulation
4.5.4.4.2 Liquid Dose Formulation
4.5.4.4.3 Injectable Dose Formulation
4.5.4.5 Medical Device
4.5.4.5.1 Class I
4.5.4.5.2 Class II
4.5.4.5.3 Class III
CHAPTER 5. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: REGIONAL MARKET ANALYSIS, BY REGION, 2018 - 2030 (USD BILLION)
5.1. Definitions & Scope
5.2. Regional Market Share Analysis, 2021 & 2030
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot
5.5. Regional Market Share, 2020
5.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
5.7. North America
5.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.7.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.7.3. U.S.
5.7.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.7.4. Canada
5.7.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8. Europe
5.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.8.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.3. Germany
5.8.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.4. U.K.
5.8.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.5. France
5.8.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.6. Italy
5.8.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.7. Spain
5.8.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.8. Netherlands
5.8.8.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.9. Belgium
5.8.9.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.10. Switzerland
5.8.10.1. Market estimates and forecast, by Services, 2016 - USD Billion)
5.8.11. Russia
5.8.11.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.12. Sweden
5.8.12.1 Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9. Asia Pacific
5.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.9.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.3. China
5.9.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.4. Japan
5.9.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.5. India
5.9.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.6. Australia
5.9.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.7. South Korea
5.9.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.8. Malaysia
5.9.8.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.9. New Zealand
5.9.9.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.10. Singapore
5.9.10.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.11. Philippines
5.9.11.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.12. Thailand
5.9.12.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10. Latin America
5.10.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.10.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.3. Brazil
5.10.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.4. Mexico
5.10.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.5. Argentina
5.10.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.6. Colombia
5.10.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.7. Chile
5.10.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11. Middle East and Africa
5.11.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.11.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.3. South Africa
5.11.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.4. Saudi Arabia
5.11.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.5. UAE
5.11.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.6. Israel
5.11.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.7. Egypt
5.11.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
CHAPTER 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET - COMPETITIVE ANALYSIS
6.1. Key companies profiled
6.1.1. Catalent Inc.
6.1.1.1. Company Overview
6.1.1.2. Financial Performance
6.1.1.3. Product Benchmarking
6.1.1.4. Strategic Initiatives
6.1.2. Lonza Group Ltd.
6.1.2.1. Company Overview
6.1.2.2. Financial Performance
6.1.2.3. Product Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Recipharm AB
6.1.3.1. Company Overview
6.1.3.2. Financial Performance
6.1.3.3. Product Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. Siegfried Holding AG
6.1.4.1. Company Overview
6.1.4.2. Financial Performance
6.1.4.3. Product Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. Thermo Fisher Scientific Inc.
6.1.5.1. Company Overview
6.1.5.2. Financial Performance
6.1.5.3. Product Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. Covance Inc.
6.1.6.1. Company Overview
6.1.6.2. Financial Performance
6.1.6.3. Product Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. Jabil
6.1.7.1. Company Overview
6.1.7.2. Financial Performance
6.1.7.3. Product Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. Sanmina Corporation
6.1.8.1. Company Overview
6.1.8.2. Financial Performance
6.1.8.3. Product Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. IQVIA Holdings Inc.
6.1.9.1. Company Overview
6.1.9.2. Financial Performance
6.1.9.3. Product Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. Flex
6.1.10.1. Company Overview
6.1.10.2. Financial Performance
6.1.10.3. Product Benchmarking
6.1.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding strategy framework, competitor categorization
1.9.4. Objective 4: Understanding key service scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing outsourcing services by pharmaceutical companies
3.4.1.2. Rising investment in R&D
3.4.1.3. Growing pharmaceutical industry
3.4.1.4. Increasing demand for one-stop-shop CDMOs
3.4.2. Market Restraint Analysis
3.4.2.1. Compliance issues while outsourcing
3.4.2.2. Changing scenarios in developing countries
3.4.2.3. Regulatory and legal compliance
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Healthcare CDMO: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.3.1. Mergers & Acquisitions
3.5.3.2. Geographic Expansions
3.5.3.3. Partnerships
3.5.3.4. Launch
3.5.3.5. Collaborations
CHAPTER 4. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: SEGMENT ANALYSIS, BY SERVICES, 2018 - 2030 (USD BILLION)
4.1. Definitions & Scope
4.2. Service market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Healthcare Contract Development & Manufacturing Organization Market, by services, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Contract Development
4.5.2. Small Molecule
4.5.2.1 Preclinical
4.5.2.1.1 Bioanalysis and DMPK studies
4.5.2.1.2 Toxicology Testing
4.5.2.1.3 Other Preclinical Services
4.5.2.2 Clinical
4.5.2.2.1 Phase I
4.5.2.2.2 Phase II
4.5.2.2.3 Phase III
4.5.2.2.4 Phase IV
4.5.2.3 Laboratory Services
4.5.2.3.1 Bioanalytical Services
4.5.2.3.2 Analytical Services
4.5.3. Large Molecule
4.5.3.1 Cell line development
4.5.3.2 Process development
4.5.3.2.1 Upstream
4.5.3.2.1.1 Microbial
4.5.3.2.1.2 Mammalian
4.5.3.2.1.3 Others
4.5.3.2.2 Downstream
4.5.3.2.2.1 MABs
4.5.3.2.2.2 Recombinant Proteins
4.5.3.2.2.3 Others
4.5.4. Contract Manufacturing
4.5.4.1 Small Molecule
4.5.4.2 Large Molecule
4.5.4.2.1 MABs
4.5.4.2.2 Recombinant Proteins
4.5.4.2.3 Others
4.5.4.3 High Potency API
4.5.4.4 Finished Dose Formulations
4.5.4.4.1 Solid Dose Formulation
4.5.4.4.2 Liquid Dose Formulation
4.5.4.4.3 Injectable Dose Formulation
4.5.4.5 Medical Device
4.5.4.5.1 Class I
4.5.4.5.2 Class II
4.5.4.5.3 Class III
CHAPTER 5. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET: REGIONAL MARKET ANALYSIS, BY REGION, 2018 - 2030 (USD BILLION)
5.1. Definitions & Scope
5.2. Regional Market Share Analysis, 2021 & 2030
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot
5.5. Regional Market Share, 2020
5.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
5.7. North America
5.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.7.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.7.3. U.S.
5.7.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.7.4. Canada
5.7.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8. Europe
5.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.8.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.3. Germany
5.8.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.4. U.K.
5.8.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.5. France
5.8.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.6. Italy
5.8.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.7. Spain
5.8.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.8. Netherlands
5.8.8.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.9. Belgium
5.8.9.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.10. Switzerland
5.8.10.1. Market estimates and forecast, by Services, 2016 - USD Billion)
5.8.11. Russia
5.8.11.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.8.12. Sweden
5.8.12.1 Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9. Asia Pacific
5.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.9.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.3. China
5.9.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.4. Japan
5.9.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.5. India
5.9.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.6. Australia
5.9.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.7. South Korea
5.9.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.8. Malaysia
5.9.8.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.9. New Zealand
5.9.9.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.10. Singapore
5.9.10.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.11. Philippines
5.9.11.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.9.12. Thailand
5.9.12.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10. Latin America
5.10.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.10.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.3. Brazil
5.10.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.4. Mexico
5.10.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.5. Argentina
5.10.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.6. Colombia
5.10.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.10.7. Chile
5.10.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11. Middle East and Africa
5.11.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
5.11.2. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.3. South Africa
5.11.3.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.4. Saudi Arabia
5.11.4.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.5. UAE
5.11.5.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.6. Israel
5.11.6.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
5.11.7. Egypt
5.11.7.1. Market estimates and forecast, by Services, 2018 - 2030 (USD Billion)
CHAPTER 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET - COMPETITIVE ANALYSIS
6.1. Key companies profiled
6.1.1. Catalent Inc.
6.1.1.1. Company Overview
6.1.1.2. Financial Performance
6.1.1.3. Product Benchmarking
6.1.1.4. Strategic Initiatives
6.1.2. Lonza Group Ltd.
6.1.2.1. Company Overview
6.1.2.2. Financial Performance
6.1.2.3. Product Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Recipharm AB
6.1.3.1. Company Overview
6.1.3.2. Financial Performance
6.1.3.3. Product Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. Siegfried Holding AG
6.1.4.1. Company Overview
6.1.4.2. Financial Performance
6.1.4.3. Product Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. Thermo Fisher Scientific Inc.
6.1.5.1. Company Overview
6.1.5.2. Financial Performance
6.1.5.3. Product Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. Covance Inc.
6.1.6.1. Company Overview
6.1.6.2. Financial Performance
6.1.6.3. Product Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. Jabil
6.1.7.1. Company Overview
6.1.7.2. Financial Performance
6.1.7.3. Product Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. Sanmina Corporation
6.1.8.1. Company Overview
6.1.8.2. Financial Performance
6.1.8.3. Product Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. IQVIA Holdings Inc.
6.1.9.1. Company Overview
6.1.9.2. Financial Performance
6.1.9.3. Product Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. Flex
6.1.10.1. Company Overview
6.1.10.2. Financial Performance
6.1.10.3. Product Benchmarking
6.1.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare CDMO Market, By Region 2018 - 2030 (USD Billion)
Table 4 Global Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 5 North America Healthcare CDMO Market, By Country, 2018 - 2030 (USD Billion)
Table 6 North America Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 7 U.S. Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 8 Canada Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 9 Europe Healthcare CDMO Market, By Country, 2018 - 2030 (USD Billion)
Table 10 Europe Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 11 U.K. Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 12 Germany Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 13 France Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 14 Italy Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 15 Spain Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 16 Netherlands Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 17 Belgium Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 18 Switzerland Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 19 Russia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 20 Sweden Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 21 Asia Pacific Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 22 China Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 23 Japan Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 24 India Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 25 Australia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 26 South Korea Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 27 Malaysia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 28 New Zealand Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 29 Singapore Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 30 Philippines Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 31 Thailand Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 32 Latin America Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 33 Brazil Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 34 Mexico Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 35 Argentina Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 36 Colombia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 37 Chile Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 38 Middle East & Africa Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 39 South Africa Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 40 Saudi Arabia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 41 UAE Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 42 Israel Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 43 Egypt Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare CDMO Market, By Region 2018 - 2030 (USD Billion)
Table 4 Global Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 5 North America Healthcare CDMO Market, By Country, 2018 - 2030 (USD Billion)
Table 6 North America Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 7 U.S. Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 8 Canada Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 9 Europe Healthcare CDMO Market, By Country, 2018 - 2030 (USD Billion)
Table 10 Europe Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 11 U.K. Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 12 Germany Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 13 France Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 14 Italy Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 15 Spain Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 16 Netherlands Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 17 Belgium Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 18 Switzerland Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 19 Russia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 20 Sweden Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 21 Asia Pacific Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 22 China Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 23 Japan Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 24 India Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 25 Australia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 26 South Korea Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 27 Malaysia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 28 New Zealand Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 29 Singapore Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 30 Philippines Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 31 Thailand Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 32 Latin America Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 33 Brazil Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 34 Mexico Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 35 Argentina Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 36 Colombia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 37 Chile Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 38 Middle East & Africa Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 39 South Africa Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 40 Saudi Arabia Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 41 UAE Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 42 Israel Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
Table 43 Egypt Healthcare CDMO Market, By Services, 2018 - 2030 (USD Billion)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Healthcare CDMO Market: Market snapshot
Fig. 9 Healthcare CDMO Market: Market segmentation
Fig. 10 Healthcare CDMO Market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Healthcare CDMO Market driver impact
Fig. 14 Healthcare CDMO Market restraint impact
Fig. 15 Healthcare CDMO Market porter’s five forces analysis
Fig. 16 Healthcare CDMO Market PESTEL analysis
Fig. 17 Healthcare CDMO Market segment dashboard
Fig. 18 Healthcare CDMO Market: Services movement Analysis
Fig. 19 Contract Development estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Contract Manufacturing estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Global Healthcare CDMO Market: Regional Outlook and key takeaways
Fig. 22 Global market share, by region
Fig. 23 North America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 France market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Netherlands market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Belgium market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Switzerland market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 China market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 39 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 India market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Malaysia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 New Zealand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Singapore market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Philippines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Colombia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Chile market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Israel market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Egypt market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Healthcare CDMO Market: Market snapshot
Fig. 9 Healthcare CDMO Market: Market segmentation
Fig. 10 Healthcare CDMO Market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Healthcare CDMO Market driver impact
Fig. 14 Healthcare CDMO Market restraint impact
Fig. 15 Healthcare CDMO Market porter’s five forces analysis
Fig. 16 Healthcare CDMO Market PESTEL analysis
Fig. 17 Healthcare CDMO Market segment dashboard
Fig. 18 Healthcare CDMO Market: Services movement Analysis
Fig. 19 Contract Development estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Contract Manufacturing estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Global Healthcare CDMO Market: Regional Outlook and key takeaways
Fig. 22 Global market share, by region
Fig. 23 North America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 France market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Netherlands market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Belgium market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Switzerland market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 China market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 39 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 40 India market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Malaysia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 New Zealand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Singapore market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Philippines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Colombia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Chile market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Israel market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Egypt market estimates and forecast, 2018 - 2030 (USD Billion)
